Successful desensitization procedure to lenalidomide in a patient with delayed hypersensitivity confirmed with a positive LTT

Eur Ann Allergy Clin Immunol. 2020 Sep;52(5):235-237. doi: 10.23822/EurAnnACI.1764-1489.134. Epub 2020 Sep 7.

Authors

I Lazzarato¹, M Gonzalez-Muñoz², R Heredia¹, F R Castellar PharmG³, A López de la Guía⁴, R Cabañas¹, A Fiandor¹, J Dominguez-Ortega¹

Affiliations

¹ Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
² Department of Immunology, Hospital La Paz, Madrid, Spain.
³ Pharmacy Service, Hospital La Paz, Madrid, Spain.
⁴ Department of Hematology, Hospital La Paz, Madrid, Spain.

PMID: 32374557
DOI: 10.23822/EurAnnACI.1764-1489.134

No abstract available

Keywords: desensitization; drug allergy; hymphocyte transformation test; lenalidomide; multiple myeloma.

Publication types

Case Reports
Letter

MeSH terms

Aged
Allergens / immunology*
Desensitization, Immunologic / methods*
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / therapy*
Humans
Hypersensitivity, Delayed / diagnosis
Hypersensitivity, Delayed / therapy*
Immunologic Tests
Lenalidomide / immunology*
Lymphocyte Activation
Male
T-Lymphocytes / immunology*
Treatment Outcome

Substances

Allergens
Lenalidomide